|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 7/08 | |
| A61K 38/10 | |||
| A61K 38/16 | |||
| C07K 14/54 | |||
| A61P 3/00 | |||
| A61P 19/02 |
| (11) | Patento numeris | 2764009 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12825032.1 |
| Europos patento paraiškos padavimo data | 2012-08-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-08-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-12-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/AU2012/000977 |
| Data | 2012-08-21 |
| (87) | Numeris | WO 2013/026089 |
| Data | 2013-02-28 |
| (30) | Numeris | Data | Šalis |
| 2011903358 | 2011-08-22 | AU | |
| 2011903360 | 2011-08-22 | AU |
| (72) |
PASPALIARIS, Vasilis, AU
LANGAN, Brett, AU
|
| (73) |
Paradigm Biopharmaceuticals Limited,
Level 2 517 Flinders Lane, Melbourne, Victoria 3000,
AU
|
| (54) | PEPTIDES FOR USE IN THE TREATMENT OF IL-1 RELATED DISEASES AND CONDITIONS |
| PEPTIDES FOR USE IN THE TREATMENT OF IL-1 RELATED DISEASES AND CONDITIONS |